Brevan Howard Capital Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-65,513
Closed -$4.88M 2277
2025
Q4
$4.88M Buy
65,513
+18,776
+40% +$1.37M 0.05% 250
2025
Q3
$3.15M Buy
46,737
+29,009
+164% +$1.93M 0.01% 386
2025
Q2
$1.16M Buy
+17,728
New +$1.06M 0.01% 999
2025
Q1
Sell
-19,436
Closed -$1.4M 1282
2024
Q4
$1.4M Buy
19,436
+8,960
+86% +$700K 0.01% 353
2024
Q3
$853K Sell
10,476
-1,498
-13% -$120K 0.01% 505
2024
Q2
$889K Sell
11,974
-2,291
-16% -$172K 0.01% 411
2024
Q1
$1.11M Buy
14,265
+3,070
+27% +$228K 0.01% 239
2023
Q4
$800K Buy
+11,195
New +$779K 0.01% 304

Other funds holding HOLX

Brevan Howard Capital Management's HOLX Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of Hologic (HOLX) in Q1 2026, closing a stake of 65,513 shares — an estimated $4.88M sold.

Brevan Howard Capital Management first reported a position in HOLX in Q4 2023 and held it in 8 quarters. The position peaked at $4.88M in Q4 2025. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Brevan Howard Capital Management reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 65,513 Hologic shares in Q1 2026, an estimated $4.88M.
  • Brevan Howard Capital Management first reported a position in Hologic in Q4 2023 and held it in 8 quarters.
  • Brevan Howard Capital Management's Hologic position peaked at $4.88M in Q4 2025.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.